4.7 Article

Exogenous administration of spermine improves glucose utilization and decreases bodyweight in mice

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 729, Issue -, Pages 94-99

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2014.01.073

Keywords

Spermine; Polyamines; Obesity; Metabolic disorder; Diabetes; Body weight

Funding

  1. Connexios Life Sciences Pvt. Ltd.
  2. Nadathur Holdings Company

Ask authors/readers for more resources

Polyamines are highly charged low molecular weight aliphatic polycations and are ubiquitously present in all living cells. In addition to their previously reported role in cell proliferation and cancer, recent studies support their role in energy homeostasis and glucose metabolism. In the present study we have evaluated a polyamine spermine for its effect on glycemic, lipid and body weight parameters. High Gat diet induced obese mice (6 week old male C57B6/J mice fed On high fat diet for 22 weeks) were dosed With spermine intraperitoneally at two different doses (5 mg/kg and 10 mg/kg body weight) for 4 weeks and its effect on body weight, glycemic and lipid parameters was monitored. We found that at a dose of 10 mg/kg bodyweight, spermine treatment resulted in a 24% reduction in the body weight and 18% reduction in the fasting glucose compared to untreated controls. Besides, spermine treated mice exhibited improved glucose utilization associated with improved fat oxidation and loss of white adipose mass. Our study is promising in the direction of exploring the spermine and their analogs for treatment of metabolic syndrome. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available